arrow
J

Ján Necpál

zvolen hospital
H指数:14
被引数:858

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Collaborative Genomics for Dystonia in Central and Eastern Europe: Successes Achieved, New Frontiers Ahead

中欧和东欧肌张力障碍的协作基因组学研究:已取得的成就,新的前沿在望

2026-04-020
OAAI
Fibroblast Transcriptomics in Molecular Diagnostics of a Comprehensive Dystonia Cohort

成纤维细胞转录组学在综合肌张力障碍队列分子诊断中的应用

2026-02-020
OAAI
Integrating Long-Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia

整合长读长纳米孔测序技术以精确解析肌张力障碍中的基因组变异

2025-09-010
OAAI
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients
Brain
IF11.7
2025-08-140
PRE
Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia

整合基因组学和蛋白质组学揭示了肌张力障碍中难以捉摸的变异和广泛的病因异质性

BRAIN
IF11.7
2025-05-0110
OA
Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early-Onset and Familial Parkinson's Disease

LRRK2 p.L1795F变异在早发型及家族性帕金森病中欧患者中的患病率及临床特征

2025-03-220
OAAI
Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder

CUL3中的功能丧失变体导致综合征性神经发育障碍

2024-09-202
PRE
ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures

ATP2B2从头变体是可变神经发育障碍的原因,其特征是肌张力障碍,共济失调,智力障碍,行为症状和癫痫发作

2023-12-015
OAAI
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study

咖啡因对ADCY5-Related运动障碍的疗效: 一项回顾性研究

2022-04-0518
PRE
Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset
BRAIN
IF11.7
2021-09-3023
OA